# Development of a Multi-omics Prediction Model for Immunotherapy Response in Triple-Negative Breast Cancer Subtypes

> **NCT06833723** · — · ACTIVE_NOT_RECRUITING · sponsor: **Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences** · enrollment: 1000 (estimated)

## Conditions studied

- Breast Neoplasms

## Interventions

- **OTHER:** Retrospective Data Collection and Analysis

## Key facts

- **NCT ID:** NCT06833723
- **Lead sponsor:** Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-04-17
- **Primary completion:** 2025-12-17
- **Final completion:** 2027-11-17
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06833723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06833723, "Development of a Multi-omics Prediction Model for Immunotherapy Response in Triple-Negative Breast Cancer Subtypes". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06833723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*